Development and characterization of a quantitative ELISA to detect anti-SARS-CoV-2 spike antibodies

A novel clinical assay for the detection and quantitation of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was adapted from an in-house, research-based enzyme-linked immunosorbent assay (ELISA). Development and validation were performed under regulatory guidelines,...

Descripción completa

Detalles Bibliográficos
Autores principales: Żak, Magdalena M., Stock, Aryeh, Stadlbauer, Daniel, Zhang, Wei, Cummings, Kirstie, Marsiglia, William, Zargarov, Arsen, Amanat, Fatima, Tamayo, Monica, Cordon-Cardo, Carlos, Krammer, Florian, Mendu, Damodara Rao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605824/
https://www.ncbi.nlm.nih.gov/pubmed/34841098
http://dx.doi.org/10.1016/j.heliyon.2021.e08444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605824/
https://www.ncbi.nlm.nih.gov/pubmed/34841098
http://dx.doi.org/10.1016/j.heliyon.2021.e08444

Ejemplares similares